Nature Reviews Drug Discovery

4.1k papers and 517.1k indexed citations i.

About

The 4.1k papers published in Nature Reviews Drug Discovery in the last decades have received a total of 517.1k indexed citations. Papers published in Nature Reviews Drug Discovery usually cover Molecular Biology (1.5k papers), Oncology (503 papers) and Immunology (492 papers) specifically the topics of Computational Drug Discovery Methods (310 papers), Pharmaceutical Economics and Policy (257 papers) and Biotechnology and Related Fields (206 papers). The most active scholars publishing in Nature Reviews Drug Discovery are Asher Mullard, Peter Kirkpatrick, Uma Yasothan, Katie Kingwell and Peter J. Kirkpatrick.

In The Last Decade

Fields of papers published in Nature Reviews Drug Discovery

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in Nature Reviews Drug Discovery. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in Nature Reviews Drug Discovery

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in Nature Reviews Drug Discovery. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in Nature Reviews Drug Discovery with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025